MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Subjective cognitive decline as predictor of objective cognitive decline in Parkinson’s patients

T. Blum, H. Wurp, S. Wolfsgruber, M. Wagner, L. Consortium, R. Dodel (Essen, Germany)

Meeting: 2023 International Congress

Abstract Number: 345

Keywords: Cognitive dysfunction, Parkinson’s

Category: Parkinson's Disease: Cognitive functions

Objective: The present study cross-sectionally and longitudinally explores the predictive value of subjective cognitive decline (SCD) regarding objective cognitive decline in a large clinical sample of Parkinson’s disease (PD) patients.

Background: 80 percent of PD patients develop cognitive impairment. In some cases, patients report SCD, that is, cognitive deficits that are not objectively measured by neuropsychological testing. While SCD in Alzheimer’s disease (AD) is established as predictor of objective cognitive decline, the role of SCD in preceding objective cognitive deficits in PD is not yet fully understood.

Method: All data was drawn from the LANDSCAPE/DEMPARK study. The sample consists of 382 patients at baseline (267 male and 115 female, 190 cognitively normal (PD-NC) and 192 mildly impaired (PD-MCI)). Cognitive performance and mental state were assessed via a neuropsychological test battery and psychometric measures. SCD was assessed via a standardized semi-structured interview as well as supplemental criteria. Based on existing research, we constructed two continuous indices to capture SCD variance: the SCD-C consisting of subjective decline in relevant cognitive areas and the SCDplus consisting of worrying, executive functioning as SCD domain, SCD onset and PD onset. Cross-validated mixed models with random intercepts were calculated for PD-NC and PD-MCI patients separately with mean squared error (MSE) between estimated and observed cognition as measure for fit, with lower MSE signifying better fit between estimated and observed cognition.

Results: In PD-NC patients excluding SCDplus and SCD-C scores yields the best results in terms of predictive performance (MSE = 5.277).  Hence, no predictive influence of SCD was found within that group. In MCI patients, including SCDplus as cross-sectional predictor improves the predictive performance and leads to the best results (MSE = 12.129) compared to a model without SCD (MSE = 12.797), while SCD-C worsens fit (MSE = 13.441), indicating that SCDplus might be a valid predictor for objective cognition in that group of patients.

Conclusion: While we find the SCDplus criteria to be predictive of objective cognitive decline in PD-MCI patients, the present results indicate a complex relation between objective and subjective cognition in PD that may differ from AD.

To cite this abstract in AMA style:

T. Blum, H. Wurp, S. Wolfsgruber, M. Wagner, L. Consortium, R. Dodel. Subjective cognitive decline as predictor of objective cognitive decline in Parkinson’s patients [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/subjective-cognitive-decline-as-predictor-of-objective-cognitive-decline-in-parkinsons-patients/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/subjective-cognitive-decline-as-predictor-of-objective-cognitive-decline-in-parkinsons-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley